• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu

Vaccines

?
-

Resources for You

July 7, 1998 Approval Letter - Engerix-B

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
Food and Drug Administration
1401 Rockville Pike
Rockville, MD 20852-1448

July 7, 1998

Our Reference Number: 97-0816

Johan Van Hoof, Ph.D.
SmithKline Beecham Biologicals
89, rue de l'Institut
1330 Rixensart
Belgium

Dear Dr. Van Hoof:

The Supplement to your Product License Application for Hepatitis B Vaccine, (Recombinant) to include the use of Hepatitis B Vaccine, (Recombinant) in individuals with chronic hepatitis C infection, has been approved.

This information will be included in your Product License Application file.

Sincerely yours,

 --- signature ---

M. Carolyn Hardegree, M.D.
Director
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research

 

Return to product page